These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8787923)
1. Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate. Fujiwara M; Ijichi K; Tokuhisa K; Katsuura K; Shigeta S; Konno K; Wang GY; Uemura D; Yokota T; Baba M Antimicrob Agents Chemother; 1996 Jan; 40(1):271-3. PubMed ID: 8787923 [TBL] [Abstract][Full Text] [Related]
2. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936 [TBL] [Abstract][Full Text] [Related]
3. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Baba M; Schols D; De Clercq E; Pauwels R; Nagy M; Györgyi-Edelényi J; Löw M; Görög S Antimicrob Agents Chemother; 1990 Jan; 34(1):134-8. PubMed ID: 2327749 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of HIV-1 replication in chronically infected cells by ingenol derivatives. Fujiwara M; Okamoto M; Ijichi K; Tokuhisa K; Hanasaki Y; Katsuura K; Uemura D; Shigeta S; Konno K; Yokota T; Baba M Arch Virol; 1998; 143(10):2003-10. PubMed ID: 9856087 [TBL] [Abstract][Full Text] [Related]
5. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Chang RS; Ding L; Chen GQ; Pan QC; Zhao ZL; Smith KM Proc Soc Exp Biol Med; 1991 May; 197(1):59-66. PubMed ID: 1708503 [TBL] [Abstract][Full Text] [Related]
6. Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR. Abreu CM; Price SL; Shirk EN; Cunha RD; Pianowski LF; Clements JE; Tanuri A; Gama L PLoS One; 2014; 9(5):e97257. PubMed ID: 24827152 [TBL] [Abstract][Full Text] [Related]
7. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication. Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677 [TBL] [Abstract][Full Text] [Related]
9. Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui. Liu Q; Li W; Huang L; Asada Y; Morris-Natschke SL; Chen CH; Lee KH; Koike K Eur J Med Chem; 2018 Aug; 156():618-627. PubMed ID: 30031972 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664 [TBL] [Abstract][Full Text] [Related]
11. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase. Pauwels R; Andries K; Debyser Z; Van Daele P; Schols D; Stoffels P; De Vreese K; Woestenborghs R; Vandamme AM; Janssen CG Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1711-5. PubMed ID: 7680476 [TBL] [Abstract][Full Text] [Related]
12. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Balzarini J; Neyts J; Schols D; Hosoya M; Van Damme E; Peumans W; De Clercq E Antiviral Res; 1992 Jun; 18(2):191-207. PubMed ID: 1329650 [TBL] [Abstract][Full Text] [Related]
13. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Coates JA; Cammack N; Jenkinson HJ; Mutton IM; Pearson BA; Storer R; Cameron JM; Penn CR Antimicrob Agents Chemother; 1992 Jan; 36(1):202-5. PubMed ID: 1590690 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400 [TBL] [Abstract][Full Text] [Related]
17. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Ashorn P; McQuade TJ; Thaisrivongs S; Tomasselli AG; Tarpley WG; Moss B Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7472-6. PubMed ID: 2217178 [TBL] [Abstract][Full Text] [Related]
18. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus. Ichimura H; Levy JA Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050 [TBL] [Abstract][Full Text] [Related]